• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Chemed Corp

    3/31/25 3:54:38 PM ET
    $CHE
    Medical/Nursing Services
    Health Care
    Get the next $CHE alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001207137
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    CHEMED CORP
    SEC File Number
    001-08351
    Address of Issuer
    SUITE 2600
    255 E FIFTH ST
    CINCINNATI
    OHIO
    45202
    Phone
    (513)762-6690
    Name of Person for Whose Account the Securities are To Be Sold
    MCNAMARA KEVIN J
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Director

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common
    Merrill Lynch
    5905 E Galbraith Road
    Suite 7000
    Cincinnati � OH � 45236
    1000605700.001463669503/31/2025
    NYSE


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common03/08/2022Stock AwardKevin J McNamaraCheckbox not checked100003/08/2022Stock Exercise

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    Kevin J McNamara
    255 E 5th St
    Suite 2600
    Cincinnati � OH � 45202
    Chemed Corporation03/06/202520001187338.00

    144: Remarks and Signature

    Remarks
    Date of Notice
    03/31/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    Marsha L Conley

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $CHE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CHE

    DatePrice TargetRatingAnalyst
    1/22/2026$475.00Buy → Hold
    Jefferies
    9/2/2025$550.00Hold → Buy
    Jefferies
    7/25/2025$500.00Hold
    Jefferies
    3/4/2022$609.00 → $579.00Outperform
    RBC Capital
    7/29/2021$604.00 → $609.00Outperform
    RBC Capital
    More analyst ratings

    $CHE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 5 filed by Westfall Nicholas Michael

    5 - CHEMED CORP (0000019584) (Issuer)

    2/5/26 11:11:30 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Director Lindell Andrea R gifted 463 units of Capital Stock, decreasing direct ownership by 8% to 5,539 units (SEC Form 4)

    4 - CHEMED CORP (0000019584) (Issuer)

    12/29/25 11:25:22 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    President and CEO Mcnamara Kevin J sold $875,100 worth of Capital Stock (2,000 units at $437.55), decreasing direct ownership by 2% to 94,197 units (SEC Form 4)

    4 - CHEMED CORP (0000019584) (Issuer)

    11/25/25 2:47:55 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26

    CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, February 25, 2026, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, February 26, 2026, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/srzsz65g. Part

    1/2/26 12:00:00 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed Corporation to Present at the BofA Securities 2025 Virtual Home Care Conference

    CINCINNATI, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2025 Virtual Home Care Conference on Tuesday, December 9, 2025, at 1:20 PM (ET). The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the

    12/4/25 12:00:00 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    New VITAS® Healthcare Video Honors Caregiver's Journey and the Power of Hospice at Home

    Stacy Noland reveals how VITAS brought comfort and dignity during her mother's final days. MIRAMAR, Fla., Nov. 25, 2025 /PRNewswire/ -- A new video released by VITAS Healthcare during National Care at Home Month spotlights the hospice story of Stacy Noland and her mother, Sonia Lindo, whose final chapter was marked by compassion and dignity. The expert end-of-life care they received allowed Noland to focus on what mattered most: being a daughter.   Lindo, a Jamaican-born cardiac nurse of 30 years saved countless lives before facing her own terminal diagnosis. "When my mother got sick, it stunned me," Noland said. "She was strong, healthy and dedicated to her patie

    11/25/25 10:50:00 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    SEC Filings

    View All

    SEC Form 10-Q filed by Chemed Corp

    10-Q - CHEMED CORP (0000019584) (Filer)

    10/31/25 9:02:17 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed Corp filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CHEMED CORP (0000019584) (Filer)

    10/28/25 4:31:00 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    SEC Form 10-Q filed by Chemed Corp

    10-Q - CHEMED CORP (0000019584) (Filer)

    7/31/25 9:05:08 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Walsh George J Iii bought $83,420 worth of Capital Stock (200 units at $417.10), increasing direct ownership by 6% to 3,523 units (SEC Form 4)

    4 - CHEMED CORP (0000019584) (Issuer)

    8/5/25 3:24:17 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    VP and Chief Legal Officer Judkins Brian C bought $75,328 worth of Capital Stock (145 units at $519.50), increasing direct ownership by 9% to 1,678 units (SEC Form 4)

    4 - CHEMED CORP (0000019584) (Issuer)

    12/30/24 11:10:35 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Chemed downgraded by Jefferies with a new price target

    Jefferies downgraded Chemed from Buy to Hold and set a new price target of $475.00

    1/22/26 8:25:02 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed upgraded by Jefferies with a new price target

    Jefferies upgraded Chemed from Hold to Buy and set a new price target of $550.00

    9/2/25 8:21:04 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Jefferies initiated coverage on Chemed with a new price target

    Jefferies initiated coverage of Chemed with a rating of Hold and set a new price target of $500.00

    7/25/25 9:06:14 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Financials

    Live finance-specific insights

    View All

    Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26

    CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, February 25, 2026, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, February 26, 2026, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/srzsz65g. Part

    1/2/26 12:00:00 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed Corporation Declares Quarterly Dividend of 60 Cents

    CINCINNATI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on December 5, 2025, to shareholders of record as of November 17, 2025. This is equal to the dividend paid in August 2025. This represents the 218th consecutive quarterly dividend paid by Chemed in its 54 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hos

    11/7/25 11:28:27 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed Reports Third-Quarter 2025 Results

    CINCINNATI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2025, versus the comparable prior-year period. Results for Quarter Ended September 30, 2025 Consolidated operating results: Revenue increased 3.1% to $624.9 millionGAAP Diluted Earnings-per-Share (EPS) of $4.46, a decrease of 10.8%Adjusted Diluted EPS of $5.27, a decrease of 6.6% VITAS segment operating results: Net Pati

    10/28/25 4:15:00 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Chemed Corp (Amendment)

    SC 13G/A - CHEMED CORP (0000019584) (Subject)

    2/13/24 5:01:01 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Chemed Corp (Amendment)

    SC 13G/A - CHEMED CORP (0000019584) (Subject)

    2/9/23 11:12:43 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Chemed Corp (Amendment)

    SC 13G/A - CHEMED CORP (0000019584) (Subject)

    2/9/22 3:33:36 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Leadership Updates

    Live Leadership Updates

    View All

    VITAS® Healthcare Announces CEO Transition and Appointment of New Chief Executive Officer

    MIRAMAR, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- VITAS Healthcare, one of the nation's leading providers of hospice and palliative care, and a subsidiary of Chemed Corporation (NYSE:CHE), today announced that Nicholas M. Westfall will step down as chairman and chief executive officer to pursue other personal and professional opportunities. Joel L. Wherley, president and chief operating officer, was appointed by the Board to succeed Westfall as chief executive officer of VITAS Healthcare. A Media Snippet accompanying this announcement is available by clicking on this link. Westfall has served as CEO since 2016, leading VITAS through a period of meaningful growth, operational transform

    7/30/25 4:22:59 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama

    VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE:CHE), announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. Covenant's hospice operations span the panhandle of Florida and Alabama, specifically including the Tallahassee, Marianna, Fort Walton Beach, Panama City, Crestview and Pensacola markets in Florida, and the Dothan and Mobile/Daphne markets in Alabama. The transaction is structured as an asset purchase and parties will seek to close the tra

    3/13/24 9:00:00 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO

    Chemed Corporation (NYSE:CHE) – Today Chemed Corporation's Board of Directors has appointed Michael D. Witzeman as Chief Financial Officer, effective January 1, 2024, following the retirement of David P. Williams from that role. Mr. Witzeman is currently Chemed's Vice President and Controller and serves as Chemed's principal accounting officer. He joined Chemed in 2005 following employment as Senior Manager of Assurance at Deloitte & Touche LLP. He is a licensed CPA and a BBA in Accounting from the University of Cincinnati and an MBA from The Ohio State University. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates t

    12/18/23 1:20:00 PM ET
    $CHE
    Medical/Nursing Services
    Health Care